Company intelligence / Profile preview

Retham Technologies

Wauwatosa / Milwaukee, Wisconsin, United Statesrethamtechnologies.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Retham Technologies is developing HITDx™, a novel in vitro diagnostic test designed to provide rapid and accurate diagnosis of Heparin-induced Thrombocytopenia. The technology stabilizes platelets for extended periods, enabling a reliable platelet activation-based assay that addresses the limitations of current tests like PF4 ELISA and SRA. Clinical studies have demonstrated its potential to improve patient outcomes by reducing false positives and unnecessary treatments. The product is not yet on the market but has received significant grant funding and recognition within the diagnostics field.

Therapeutic areas: Hematology
Modalities: In vitro diagnostic assay (IVD)Device (diagnostic)
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

HITDx

Pre-clinical

Indications: Heparin-induced thrombocytopenia, Vaccine-induced immune thrombotic thrombocytopenia

Partnerships

Blood Center of Wisconsin (technology translation partner)

Beyond the preview

Go deeper on Retham Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retham Technologies.

Explore the full profile